T Feyerabend
Overview
Explore the profile of T Feyerabend including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
83
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Feyerabend T, Steeves R, Jager B, Wiedemann G, Sommer K, Richter E, et al.
Int J Oncol
. 2011 May;
10(3):591-5.
PMID: 21533418
Large tumor size is a negative prognostic variable for attaining complete regression (CR) with local hyperthermia (HT) and radiotherapy (RT). Such poor prognosis lesions (i.e., >7 cm(2) or >14 cm(3))...
2.
Fehlauer F, Weinhold H, Kolberg H, Lindenkamp M, Schulte R, Mahlmann B, et al.
Zentralbl Gynakol
. 2005 Feb;
127(1):31-6.
PMID: 15702448
Objective: To evaluate mono-institutional results concerning tumor free survival, overall survival, local tumor control and rate of distant metastasis following breast-conserving therapy. Patients And Methods: Retrospectively, 274 breast cancer patients...
3.
Ressel A, Schmitt O, Weiss C, Feyerabend T
Eur J Cancer
. 2002 Mar;
38(4):594-601.
PMID: 11872355
The aim of the study was to optimise the still unsatisfactory therapeutic results in head and neck cancer by studying the results and the side-effects of radiotherapy, chemotherapy and/or local...
4.
Buttner H, Feyerabend T, Bohle A
Urologe A
. 2001 Oct;
40(5):380-3.
PMID: 11594212
Radical cystectomy is the current standard therapy for muscle invasive or locally advanced transitional cell carcinoma of the bladder. Organ-preserving monotherapeutic alternatives (e.g. transurethral resection, radiotherapy) do not lead to...
5.
Vacha P, Buttner H, Bohle A, Feyerabend T
Urologe A
. 2001 Oct;
40(5):376-9.
PMID: 11594211
Radiotherapy of bladder cancer is a locally effective therapeutic approach. It is increasingly becoming part of the multimodal protocols aimed at the preservation of both organ and organ function. In...
6.
Doehn C, Feyerabend T
Urologe A
. 2001 Aug;
40(4):313-4.
PMID: 11490866
Some authors report successful use of radiochemotherapy in patients with penile cancer. The most promising chemotherapeutic agents in penile cancer are cisplatin, methotrexate, bleomycin, vinblastine, and vincristine. There are different...
7.
Mahlmann B, Doehn C, Feyerabend T
Urologe A
. 2001 Aug;
40(4):308-12.
PMID: 11490865
Penile cancer is rare. Thus, there are no therapeutic recommendations fulfilling the requirements of evidence-based medicine. The empirically based therapeutic approach consists of local excision, laser therapy, or radiotherapy with...
8.
Nadrowitz R, Feyerabend T
Med Phys
. 2001 Jul;
28(6):959-65.
PMID: 11439492
If metallic material is exposed to ionizing radiation of sufficient high energy, an increase in dose due to backscatter radiation occurs in front of this material. Our purpose in this...
9.
Stallmann C, Vacha P, Vesely H, Richter E, Feyerabend T
Strahlenther Onkol
. 2001 Jun;
177(5):247-51.
PMID: 11398610
Background: With 17.6% of all primary parotid neoformations the benign Warthin's tumor (cystadenolymphoma) is the second common parotid gland tumor. Males > 50 years are affected predominantly. After surgery the...
10.
Sommer K, Peters S, Robins I, Raap M, Wiedemann G, Remmert S, et al.
Int J Oncol
. 2001 May;
18(6):1145-9.
PMID: 11351243
We developed a mouse model in a representative human derived head and neck cancer cell line for preclinical studies to evaluate antitumor response, tumor-free survival and host toxicity of alkylating...